Bavarian company making advanced biomaterials based on silk proteins produced by microorganisms.
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Funding round AMSilk raised €52 million (€30 in equity, €22 in convertible bonds) led by ATHOS to scale industrial production of its silk-based biomaterials. | $60.3M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.